Pharmaceuticals, Biotechnology and Life Sciences
OXFORDSHIRE, England & CONSHOHOCKEN, Pa. & ROCKVILLE, Md.–(BUSINESS WIRE)–Immunocore Limited, a leading T cell receptor (TCR) biotechnology company, presented new…
Company currently evaluating potential partnerships with animal health pharmaceutical companies Treatment of arthritis in canines is an estimated $1.9 billion…
–Platform enables greater accuracy and efficiency in target validation and preclinical assessment of prospective therapies for kidney disease– CAMBRIDGE, Mass.–(BUSINESS…
The FDA also granted Opdivo plus Yervoy Breakthrough Therapy Designation for this potential indication PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol-Myers Squibb Company…
DUBLIN–(BUSINESS WIRE)–The “Xyzall – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. “Xyzall Drug Insight, 2019” highlights the…
DUBLIN–(BUSINESS WIRE)–The “Xermelo- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. “Xermelo Drug Insight, 2019” highlights the drug…
DUBLIN–(BUSINESS WIRE)–The “Ibrance – Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. “Ibrance Drug Insight, 2019” highlights the…
DUBLIN–(BUSINESS WIRE)–The “Zeclar- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. “Zeclar Drug Insight, 2019” highlights the drug…
Phase 1 clinical data show that subcutaneous administration of RUC-4 resulted in a potent, rapid, and sustained platelet inhibition effect;…
Mereo BioPharma Group’s Phase 2b dose-ranging “Asteroid” clinical study of setrusumab (BPS-804), an anti-sclerostin antibody, in adults with Type I,…